256 related articles for article (PubMed ID: 29440428)
1. Contribution of NIH funding to new drug approvals 2010-2016.
Galkina Cleary E; Beierlein JM; Khanuja NS; McNamee LM; Ledley FD
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):2329-2334. PubMed ID: 29440428
[TBL] [Abstract][Full Text] [Related]
2. NIH funding for patents that contribute to market exclusivity of drugs approved 2010-2019 and the public interest protections of Bayh-Dole.
Ledley FD; Cleary EG
PLoS One; 2023; 18(7):e0288447. PubMed ID: 37494368
[TBL] [Abstract][Full Text] [Related]
3. Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry.
Zhou EW; Jackson MJ; Ledley FD
JAMA Health Forum; 2023 Jul; 4(7):e231921. PubMed ID: 37450296
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019.
Galkina Cleary E; Jackson MJ; Zhou EW; Ledley FD
JAMA Health Forum; 2023 Apr; 4(4):e230511. PubMed ID: 37115539
[TBL] [Abstract][Full Text] [Related]
5. Financing of U.S. biomedical research and new drug approvals across therapeutic areas.
Dorsey ER; Thompson JP; Carrasco M; de Roulet J; Vitticore P; Nicholson S; Johnston SC; Holloway RG; Moses H
PLoS One; 2009 Sep; 4(9):e7015. PubMed ID: 19750225
[TBL] [Abstract][Full Text] [Related]
6. A review of policy dissemination and implementation research funded by the National Institutes of Health, 2007-2014.
Purtle J; Peters R; Brownson RC
Implement Sci; 2016 Jan; 11():1. PubMed ID: 26727969
[TBL] [Abstract][Full Text] [Related]
7. National Institutes of Health funding among vascular surgeons is rare.
Mirzaie AA; Cooper MA; Weaver ML; Jacobs CR; Cox ML; Berceli SA; Scali ST; Back MR; Huber TS; Upchurch GR; Shah SK
J Vasc Surg; 2023 Oct; 78(4):845-851. PubMed ID: 37327950
[TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health Funding for Tobacco Control: 2006 and 2016.
Merianos AL; Gordon JS; Wood KJ; Mahabee-Gittens EM
Am J Health Promot; 2019 Feb; 33(2):279-284. PubMed ID: 29847996
[TBL] [Abstract][Full Text] [Related]
9. Scholarly investigation into otitis media: who is receiving funding support from the National Institutes of Health?
Hojjat H; Johnson AP; Svider PF; Hong RS; Zuliani G; Folbe AJ; Shkoukani MA
Laryngoscope; 2015 Jul; 125(7):1708-14. PubMed ID: 25684148
[TBL] [Abstract][Full Text] [Related]
10. National Institutes of Health Funding to Departments of Orthopaedic Surgery at U.S. Medical Schools.
Silvestre J; Ahn J; Levin LS
J Bone Joint Surg Am; 2017 Jan; 99(2):e5. PubMed ID: 28099310
[TBL] [Abstract][Full Text] [Related]
11. Disparities in National Institute of Health trauma research funding: The search for sufficient funding opportunities.
Dowd B; McKenney M; Boneva D; Elkbuli A
Medicine (Baltimore); 2020 Feb; 99(6):e19027. PubMed ID: 32028413
[TBL] [Abstract][Full Text] [Related]
12. Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals.
Hao J; Rodriguez-Monguio R; Seoane-Vazquez E
PLoS One; 2015; 10(10):e0140708. PubMed ID: 26469277
[TBL] [Abstract][Full Text] [Related]
13. Citations in Life Science Patents to Publicly Funded Research at Academic Medical Centers.
Sampat BN; Pincus HA
Clin Transl Sci; 2015 Dec; 8(6):759-63. PubMed ID: 26728947
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of National Institutes of Health funding for academic thoracic surgeons.
Narahari AK; Mehaffey JH; Chandrabhatla AS; Hawkins RB; Charles EJ; Roeser ME; Lau C; Ailawadi G
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):872-879.e2. PubMed ID: 33676759
[TBL] [Abstract][Full Text] [Related]
15. National Institutes of Health grant awards for pain, nausea, and dyspnea research: an assessment of funding patterns in 2003.
Bradshaw DH; Nakamura Y; Chapman CR
J Pain; 2005 May; 6(5):277-93. PubMed ID: 15890630
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health Funding to Departments of Orthopaedic Surgery at U.S. Medical Schools from 2015 to 2021.
Imam N; Sudah SY; Shaikh SZ; Nicholson AD; Namdari S; Menendez ME
J Bone Joint Surg Am; 2023 Aug; 105(15):1205-1213. PubMed ID: 37079660
[TBL] [Abstract][Full Text] [Related]
17. [Investigation on new molecular entities of drugs approved in three regions, Japan, U.S. and EU--common and preceding approvals in current 4 years].
Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2006; (124):80-2. PubMed ID: 17405529
[TBL] [Abstract][Full Text] [Related]
18. Cerebral palsy research funding from the National Institutes of Health, 2001 to 2013.
Wu YW; Mehravari AS; Numis AL; Gross P
Dev Med Child Neurol; 2015 Oct; 57(10):936-41. PubMed ID: 25951080
[TBL] [Abstract][Full Text] [Related]
19. Little science, big science: strategies for research portfolio selection in academic surgery departments.
Shah A; Pietrobon R; Cook C; Sheth NP; Nguyen L; Guo L; Jacobs DO; Kuo PC
Ann Surg; 2007 Dec; 246(6):1110-5. PubMed ID: 18043118
[TBL] [Abstract][Full Text] [Related]
20. Trends in National Institutes of Health Funding of Principal Investigators in Dermatology Research by Academic Degree and Sex.
Cheng MY; Sukhov A; Sultani H; Kim K; Maverakis E
JAMA Dermatol; 2016 Aug; 152(8):883-8. PubMed ID: 27191545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
